Alterity Therapeutics (ATHE) Goodwill & Intangibles (2020 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Goodwill & Intangibles of $4.0 million for Q4 2025, up 17.72% quarter-over-quarter from $3.4 million in Q2 2025.
Alterity Therapeutics (ATHE) Goodwill & Intangibles (2020 - 2025) Analysis & Trends
Alterity Therapeutics' Goodwill & Intangibles history runs 2 years deep, the most recent figure standing at $4.0 million for Q4 2025.
- In Q4 2025, Goodwill & Intangibles changed N/A year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (changed N/A YoY), while the FY2025 annual figure was $3.4 million, changed N/A from the prior year.
- Goodwill & Intangibles for Q4 2025 stood at $4.0 million, up from $3.4 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $4.0 million in Q4 2025, with the low at $3.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.03 Mn |
| Jun 30, 2025 | 3.42 Mn |
| Dec 31, 2020 | 119.13 Mn |
| Jun 30, 2020 | 96.27 Mn |